City
Epaper

INSACOG calls for COVID vaccine booster dose to those at-risk, above 40 years

By ANI | Updated: December 3, 2021 12:55 IST

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has called for the administration of a COVID-19 vaccine booster dose for those who are above 40 years of age and at-risk people, informed an official statement issued by INSACOG on Monday.

Open in App

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has called for the administration of a COVID-19 vaccine booster dose for those who are above 40 years of age and at-risk people, informed an official statement issued by INSACOG on Monday.

The body, in its bulletin on November 29, has said that those who are above 40 years of age and at high risk or high exposure may be considered as a priority for the booster dose.

"Vaccination of all remaining unvaccinated at-risk people and consideration of a booster dose for those 40 years of age and over, first targeting the most high-risk or high-exposure may be considered since low levels of neutralising antibodies from current vaccines are unlikely to be sufficient to neutralise Omicron, although the risk of severe disease is still likely to be reduced," INSACOG statement said.

INSACOG also said "Genomic surveillance will be critical for early detection of the presence of this variant, to enable necessary public health measures. Monitoring travel to and from the known affected areas and contact tracing of COVID-19 cases with an epidemiological link to the affected areas has been implemented along with increased testing (with the sequencing of confirmed cases and possible SGTF based rapid screening)."

Earlier on Thursday, the Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country.

The officials informed that the demand has been made due to the emergence of a new coronavirus variant 'Omicron'.

The new Omicron variant was first reported to the World Health Organization (WHO) by South Africa on November 24. According to the WHO, its high number of mutations in spike protein could make it more transmissible than all previous strains. South African medical officials have reported the variant was found in fully vaccinated individuals and the cases are mild.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Structural Genomics ConsortiumInsacog
Open in App

Related Stories

NationalINSACOG to hold meeting today on genome sequencing and presence of different Covid19 variants in country

NationalOmicron, sub-lineages remain dominant variant in India: INSACOG

NationalNo Covid XE variant in India, Govt sources deny media reports confirming first case

MaharashtraOmicron's community spread in Mumbai; says INSACOG's report

HealthOmicron in community transmission stage in India: INSACOG

National Realted Stories

NationalResidents in Dehradun reap benefits of Jan Aushadhi Kendra, express gratitude to Modi govt

NationalBharatiya Kisan Union (Ekta-Sidhupur) protests against Punjab govt for not giving compensation for destroyed crops

NationalHaryana Minister inspects arrangements for water drainage in Gurugram

National'We must stand as one': A plea for peace after the Pahalgam attack

NationalFour of family killed as car hits bike in Madhya Pradesh